Literature DB >> 9496465

Ultrastructural changes during myocardial hypertrophy and its regression: long-term effects of nifedipine in adult spontaneously hypertensive rats.

T Kimpara1, M Okabe, H Nishimura, T Hayashi, K Imamura, K Kawamura.   

Abstract

Nifedipine (20 mg/kg/day) was given to 15-week-old spontaneously hypertensive rats for 20 weeks (SHR-N, n = 8). Comparison was done with sex-matched 15-week-old SHR (SHR-15, n = 7), untreated 35-week-old SHR (SHR-C, n = 10), 15-week-old normotensive Wistar-Kyoto rats (WKY-15, n = 15), and 35-week-old WKY (WKY-15, n = 5). Light and electron microscopic data on the subepicardial, middle and subendocardial layers and papillary muscles of the left ventricle were compared among the five rat groups. In SHR-N, blood pressure was significantly reduced by nifedipine, but was higher than in WKY-35 (199 +/- 11 mmHg vs 121 +/- 13 mmHg). The left ventricular weight/body weight ratio was much lower in SHR-N than in SHR-C, and was even below the baseline value in SHR-15. In addition, cardiac myocyte diameter was much smaller in each myocardial layer of SHR-N than in SHR-C, and was similar to the findings in SHR-15, but still larger than in WKY-35. The interstitial area ratio was markedly reduced in SHR-N and did not differ from that in SHR-15 or even WKY-15, while capillary density was significantly greater than in SHR-C and comparable to that in WKY-35. In SHR-C, large fibrotic foci were common, and many hypertrophic cardiac myocytes showed various degenerative changes including those of mitochondria and widening of the intermyofibrillar spaces. These changes were rarely seen in SHR-N. The intracellular volume ratio of myofibrils did not differ between SHR-N and WKY-35, but was significantly decreased in SHR-C, whereas that of mitochondria did not differ between SHR-N and SHR-C or WKY-35. These findings indicate that despite only a moderate suppression of hypertension, long-term nifedipine treatment caused regression of left ventricular hypertrophy, with cardiocyte hypertrophy, interstitial fibrosis, degenerative changes, and subcellular remodeling being reversed to the baseline levels in SHR-15. In addition, the capillary density was increased to that seen in WKY-35.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9496465     DOI: 10.1007/BF02767132

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  17 in total

Review 1.  Regression of cardiac hypertrophy and left ventricular pumping ability postregression.

Authors:  E D Frohlich
Journal:  J Cardiovasc Pharmacol       Date:  1991       Impact factor: 3.105

2.  Left ventricular filling pattern in hypertensive patients after reversal of myocardial hypertrophy.

Authors:  L Agati; F Fedele; M Penco; S Sciomer; A Dagianti
Journal:  Int J Cardiol       Date:  1987-11       Impact factor: 4.164

3.  Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.

Authors:  R E Schmieder; P Martus; A Klingbeil
Journal:  JAMA       Date:  1996-05-15       Impact factor: 56.272

4.  Left ventricular diastolic function of spontaneously hypertensive rats and its relationship to structural components of the left ventricle.

Authors:  H Nishimura; S Kubo; A Nishioka; K Imamura; K Kawamura; M Hasegawa
Journal:  Clin Sci (Lond)       Date:  1985-11       Impact factor: 6.124

Review 5.  Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy.

Authors:  W H Frishman; A E Skolnick; J A Strom
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

6.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

7.  Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Diastolic mechanisms for systolic dysfunction during exercise.

Authors:  A Cuocolo; F L Sax; J E Brush; B J Maron; S L Bacharach; R O Bonow
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

8.  Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment.

Authors:  M L Muiesan; M Salvetti; D Rizzoni; M Castellano; F Donato; E Agabiti-Rosei
Journal:  J Hypertens       Date:  1995-10       Impact factor: 4.844

9.  Cardiac hypertrophy: useful adaptation or pathologic process?

Authors:  W Grossman
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

Review 10.  Evaluation of the cardiac effects of antihypertensive agents.

Authors:  E Agabiti-Rosei
Journal:  J Cardiovasc Pharmacol       Date:  1994       Impact factor: 3.105

View more
  1 in total

1.  Remodeling of cardiomyocytes and their branches in juvenile, adult, and senescent spontaneously hypertensive rats and Wistar Kyoto rats: comparative morphometric analyses by scanning electron microscopy.

Authors:  M Okabe; K Kawamura; F Terasaki; T Hayashi
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.